Linqvist Leonardsen Ann-Chatrin, Lunde Ellen Marie, Andersen Mona Sand
Østfold Hospital Trust, Grålum, Norway.
Østfold University College/Østfold Hospital Trust, Halden, Norway.
SAGE Open Nurs. 2025 Aug 19;11:23779608251367258. doi: 10.1177/23779608251367258. eCollection 2025 Jan-Dec.
The majority of hospitalized patients require vascular access for intravenous medical treatment. A peripherally inserted central catheter (PICC) may be indicated for long-term treatment. In many Norwegian hospitals, this is a nurse anesthetist-led initiative.
The aim of this study was to examine the use of PICCs from insertion to completed treatment and to assess potential risk factors for the development of catheter-related complications.
A quantitative prospective, longitudinal design was used. Data were collected via electronic patient records, as well as through telephone surveys with patients every fourth week until the catheter was discontinued. The Statistical Package for the Social Sciences version 28 was used for analysis.
In total, 401 PICCs were included. The primary indications were antibiotic treatment ( = 272), nutrition ( = 46), or chemotherapy ( = 42). A total of 163 PICCs were used for a period of over 30 days. Overall, 41 catheter-related complications were identified through patient records. Erythema at the insertion site ( = 12) was the most common complication, and the most severe complications were deep venous thrombosis ( = 5) and confirmed catheter-related infection ( = 4). After 4 weeks, 12 patients reported complications, with pain/numbness ( = 4) being the most frequent. The study demonstrated no statistically significant covariation between the occurrence of complications and age, length of time the catheter was in use, primary indication, venous diameter, or the number of insertion attempts.
The study showed a low incidence of severe PICC-related complications. Peripherally inserted central catheters were inserted and used according to local guidelines. The study indicates that nurse anesthetists' knowledge and experience can be utilized in the future selection and insertion of vascular access for patients, as well as in training and education on PICCs.
大多数住院患者需要通过血管通路进行静脉药物治疗。外周静脉穿刺中心静脉导管(PICC)可用于长期治疗。在许多挪威医院,这是由麻醉护士主导的一项工作。
本研究旨在检查PICC从置入到完成治疗的使用情况,并评估导管相关并发症发生的潜在风险因素。
采用定量前瞻性纵向设计。通过电子病历收集数据,并每四周对患者进行一次电话调查,直至导管拔除。使用社会科学统计软件包第28版进行分析。
共纳入401根PICC。主要适应证为抗生素治疗(n = 272)、营养支持(n = 46)或化疗(n = 42)。共有163根PICC使用时间超过30天。总体而言,通过患者记录共识别出41例导管相关并发症。穿刺部位红斑(n = 12)是最常见的并发症,最严重的并发症是深静脉血栓形成(n = 5)和确诊的导管相关感染(n = 4)。4周后,12例患者报告出现并发症,其中疼痛/麻木(n = 4)最为常见。该研究表明,并发症的发生与年龄、导管使用时间、主要适应证、静脉直径或穿刺尝试次数之间无统计学显著相关性。
该研究显示PICC相关严重并发症的发生率较低。外周静脉穿刺中心静脉导管的置入和使用符合当地指南。该研究表明,麻醉护士的知识和经验可用于未来患者血管通路的选择和置入,以及PICC的培训和教育。